Women's Health Library
Every article, presentation, spotlight, and news item we've tagged to Women's Health.
Showing 49–54 of 54
Reducing cardiovascular risk: a playbook for lipid-lowering pharmacotherapy
A systematic approach to lipid-lowering pharmacotherapy uses risk stratification and a six-step protocol to guide drug selection and escalation, optimizing cardiovascular protection across heterogeneous patient populations. This framework addresses the gap between guideline recommendations and individualized clinical decision-making in managing atherosclerotic cardiovascular disease risk.
NOVOS trial explores vascular aging markers
A randomized, double-blind, placebo-controlled trial in 43 healthy adults over 40 found that a multi-component nutritional intervention improved endothelial function by 2.9%, reduced arterial stiffness by 1.18 m/s, and lowered systolic blood pressure by 6.1 mmHg over six months. These improvements in vascular function markers suggest the intervention may address structural and functional aging of the arterial system, with effect sizes comparable to or exceeding those from exercise interventions.
Novos trial shows cardiovascular benefits in aging adults
A Novos clinical trial demonstrated statistically significant reductions in systolic and diastolic blood pressure, improved lipid profiles, and favorable shifts in metabolic markers among adults over 40 following the company's integrated lifestyle and metabolic support program. These findings support multimodal intervention as an approach to reducing established cardiovascular risk factors associated with aging.
#388 — Prostate cancer screening: why current PSA guidelines are failing men and how modern tools improve early detection and save lives
Current PSA-based prostate cancer screening protocols miss clinically significant cancers and fail to distinguish aggressive from indolent disease, reducing detection effectiveness. Modern biomarkers and imaging technologies enable earlier identification of aggressive tumors when intervention is most effective, fundamentally altering outcomes for men at risk.
Estropausal gut microbiota transplant improves measures of ovarian function in adult mice
Transplanting gut microbiota from aging female mice into young adults restored ovarian hormone profiles, follicle development, and fertility markers, establishing a causal relationship between age-related changes in the microbiome and ovarian function decline. This demonstrates that microbiota composition directly regulates reproductive capacity independent of chronological age.
Medication Reduction Improves Health Without Needing Better Outcomes
Deprescribing—reducing or stopping medications when risks outweigh benefits—need not improve disease outcomes to provide clinical value. The practice delivers measurable benefits through reduced adverse effects, improved quality of life, and lower costs, making it a valid optimization strategy independent of disease-specific efficacy metrics.